Transforming medical imaging in Scotland with AI
The global shortage of radiologists is having a serious impact on diagnostics and delaying medical treatments, but AI tools for…
Partner Content
-
-
Bio-based plastics for biopharma: How is parenteral packaging adopting eco-design?
In a parenteral packaging world often dominated by discussion of vials, stoppers, and pre-filled syringes, flip caps rarely take centre…
-
Utilizing data-driven insights for digital health solutions
Digital health technologies are changing how care is delivered, but how do we substantiate claims that these innovations are effective?…
-
Regulatory factors in rare disease studies
The rare disease landscape poses myriad challenges for researchers, policymakers, and CROs, particularly in navigating its intricate regulatory environment. Rare…
-
Oncology trials: Delivering precision and reliability in data management
Clinical trials for oncology are filled with data management complexities that must be carefully navigated, with challenges and solutions outlined…
-
What matters in the API market as 2026 approaches
The active pharmaceutical ingredient (API) landscape is shifting. Companies are rethinking their sourcing strategies, upgrading their technological capabilities, and relying…
-
The CGT frontier: what to prioritise in the transition from clinical to commercial
Projections show a $177.46 billion market by 2034 and an 18.7% CAGR. But here's the reality check: current manufacturing capacity…
-
The next act for mRNA: pushing boundaries in cell and gene therapy
The use of mRNA in therapeutics is growing ever wider following its success in Moderna’s and BioNTech’s Covid-19 vaccine programmes.…
-
Aseptic filling of unstable drug products: How to protect sensitive drugs during the fill finish process
This article explores the typical fill-finish process, the potential impact on unstable drug products, and best practices to protect these…
-
The rise of large-volume injectors: Patient-centric innovation in biologics delivery
For decades, intravenous (IV) infusions in clinical settings were the standard for therapies such as monoclonal antibodies. Today, advances in…